Xitogen Technologies

Suzhou, China Founded: 2013 • Age: 13 yrs Acquired By Beckman Coulter
Flow cytometer research applications are developed for nanoscale object detection.

About Xitogen Technologies

Xitogen Technologies is a Healthcare company based in Suzhou (China) founded in 2013, and was acquired by Beckman Coulter in April 2014. Flow cytometer research applications are developed for nanoscale object detection. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Cell Biology.

Company details

Xitogen Technologies was established in 2013 in Suzhou, China, within the biotechnology sector. Research applications for flow cytometry are developed, focusing on detection technologies. The XTG-1600 cytometer, with its compact design, is produced to identify objects in the 100-nanometer range, including viruses, bacteria, microparticles, and cell organelles. Operations center on advancing tools for scientific and medical research in this field.

Key Metrics

Investors in Xitogen Technologies

Xitogen Technologies has secured backing from 1 investor. Prominent investors backing the company include Beckman Coulter.

All
InvestorDescriptionFounded YearDomainLocation
Clinical diagnostic products are manufactured for biomedical testing.
1935beckmancoulter.comBrea, United States
Premium access

Investor details for Xitogen Technologies

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Xitogen Technologies

2 dated milestones of Xitogen Technologies across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded Xitogen Technologies is founded.
  2. Exit Acquired by Beckman Coulter.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Xitogen Technologies

Xitogen Technologies was founded in 2013.

Xitogen Technologies is headquartered in Suzhou, China. It is registered at Suzhou, Jiangsu, China.

Xitogen Technologies was established in 2013 in Suzhou, China, within the biotechnology sector. Research applications for flow cytometry are developed, focusing on detection technologies. The XTG-1600 cytometer, with its compact design, is produced to identify objects in the 100-nanometer range, including viruses, bacteria, microparticles, and cell organelles. Operations center on advancing tools for scientific and medical research in this field.

Xitogen Technologies has 1 investor. Key investors include Beckman Coulter.

Yes. Xitogen Technologies was acquired by Beckman Coulter in April 2014.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available